Publication & Citation Trends
Publications
69 total
Treatment outcomes of radium-223 in patients with metastatic castration-resistant prostate cancer: An experience before National Health Insurance reimbursement in Taiwan OA
Cited by 2
Semantic Scholar
Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence OA
Cited by 4
Semantic Scholar
MP69-12 THE PREDICTION OF RENAL FUNCTION CHANGE AFTER UNILATERAL NEPHROURETERECTOMY IN UPPER TRACT UROTHELIAL CARCINOMA PATIENTS BY USING TC-99M MAG3 RENAL SCAN
Cited by 0
Semantic Scholar
Darolutamide for non-metastatic castration-resistant prostate cancer: Efficacy, safety, and clinical perspectives of use. OA
Cited by 4
Semantic Scholar
Adjuvant pembrolizumab (pembro) for renal cell carcinoma (RCC) across UCLA Integrated Staging System (UISS) risk groups and disease stage: Subgroup analyses from the KEYNOTE-564 study.
Cited by 6
Semantic Scholar
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma OA
Cited by 19
Semantic Scholar
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study.
Cited by 109
Semantic Scholar
Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma: Results from 30-month follow-up of KEYNOTE-564.
Cited by 21
Semantic Scholar
Research Topics
Renal cell carcinoma treatment
(31)
Bladder and Urothelial Cancer Treatments
(23)
Renal and related cancers
(14)
Cancer Immunotherapy and Biomarkers
(11)
Urinary and Genital Oncology Studies
(10)
Affiliations
National Yang Ming Chiao Tung University
National Taiwan University
Chang Gung University
Université Paris-Saclay
Institut Gustave Roussy